NHS Launches RSV Vaccine for Vulnerable Groups
New vaccination program targets pregnant women and seniors to reduce hospital admissions and ease winter pressures.
- RSV vaccine now available to pregnant women from 28 weeks and adults over 75.
- The program aims to prevent severe RSV cases, particularly in infants and the elderly.
- RSV can cause serious respiratory issues, including bronchiolitis and pneumonia.
- Health officials highlight the vaccine's role in reducing NHS winter burden.
- Public urged to adopt additional hygiene measures to curb virus spread.